Information  X 
Enter a valid email address

Puretech Health PLC Ord 1P (PRTC)

Date Time Source Announcement
05 Nov 2019 1:00 pm
RNS
PRTC Presents Novel Oncology Program Data at SITC
  11:00 am
RNS
Gelesis Shares New Plenity Safety & Efficacy Data
28 Oct 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
24 Oct 2019 7:00 am
RNS
Sonde Names Healthcare Tech Exec David Liu as CEO
18 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
02 Oct 2019 7:00 am
RNS
Minority Stake Acquisition & PDMR Notification
01 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  1:15 pm
RNS
Vor Appoints Senior Cell & Gene Therapy Leaders
  7:00 am
RNS
Total Voting Rights
23 Sep 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Vedanta Expands Series C with $62.1M Total Raised
16 Sep 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
09 Sep 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
PureTech Announces Board Change
06 Sep 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Sep 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
27 Aug 2019 7:00 am
RNS
PureTech Health plc Half-Year Report
20 Aug 2019 7:00 am
RNS
Notice of Results
19 Aug 2019 12:02 pm
RNS
Price Monitoring Extension
14 Aug 2019 5:30 pm
RNS
BTG
07 Aug 2019 1:40 pm
RNS
Vor Names Biotech Vet Robert Ang President & CEO
01 Aug 2019 7:00 am
RNS
Total Voting Rights
31 Jul 2019 1:40 pm
RNS
Vor Biopharma Adds R&D Leader Bill Lundberg to BOD
17 Jul 2019 7:00 am
RNS
PRTC Acquires Clinical Stage Asset for Lymphedema
11 Jul 2019 7:00 am
RNS
Potential US Listing of PureTech Health on Nasdaq
09 Jul 2019 7:00 am
RNS
PRTC Immuno-Oncology Programme Granted US Patent
03 Jul 2019 7:00 am
RNS
PRTC's Karuna closes IPO, gross proceeds $102.6M
01 Jul 2019 7:00 am
RNS
First Patient in Vedanta Food Allergy Study
28 Jun 2019 7:00 am
RNS
PureTech's Karuna successfully lists on NASDAQ
20 Jun 2019 7:00 am
RNS
PureTech Announces New Corporate HQ/Internal Labs
13 Jun 2019 7:00 am
RNS
Follica Positive Interim Data & Plans for Pivotal
03 Jun 2019 7:00 am
RNS
PRTC's Karuna Files Public S1 for NASDAQ IPO
30 May 2019 7:05 am
RNS
PRTC to Present at Jefferies US Conference
  7:00 am
RNS
Result of AGM
29 May 2019 7:00 am
RNS
Vor Publishes POC Study in Scientific Journal
21 May 2019 7:00 am
RNS
Vedanta Presents Expanded Data from Successful Ph1
20 May 2019 7:00 am
RNS
Promising Gelesis Data in Chronic Constipation
14 May 2019 7:00 am
RNS
Gelesis & Vedanta Data at Digestive Disease Week
13 May 2019 7:00 am
RNS
Vedanta Grows Series C Financing to $45.5 Million
07 May 2019 7:00 am
RNS
Vedanta Prevails in Important EU Patent Opposition
26 Apr 2019 7:15 am
RNS
PRTC's Karuna Files IPO Registration Statement
25 Apr 2019 7:00 am
RNS
Gelesis Gets $10.6M Grant to Support Manufacturing
24 Apr 2019 7:00 am
RNS
Final Results
17 Apr 2019 7:00 am
RNS
Boehringer Ingelheim & PRTC Immuno-oncology Collab
15 Apr 2019 7:00 am
RNS
Gelesis Receives FDA Clearance for First Product
11 Apr 2019 1:00 pm
RNS
Akili Makes CFO & General Counsel Appointments
  7:05 am
RNS
Gelesis Presents Data on Effects of High-Fat Diet
  7:00 am
RNS
Sonde Completes $16M Series A Financing Round
02 Apr 2019 7:00 am
RNS
PRTC Presents Immuno-Oncology Programmes at AACR
01 Apr 2019 12:05 pm
RNS
Karuna expands Series B financing to $80 million
25 Mar 2019 6:00 pm
RNS
Gelesis New Clinical Data on Impact of Gelesis100
  6:00 pm
RNS
Gelesis Preclinical Data on Restoring Gut Barrier
21 Mar 2019 7:00 am
RNS
Gelesis to Present at Endocrine Society Annual Mtg
18 Mar 2019 7:00 am
RNS
Karuna Announces $68 Million Series B Financing
15 Mar 2019 7:00 am
RNS
Notice of Results
07 Mar 2019 7:00 am
RNS
Akili & Shionogi Deal in Taiwan/Japan $20M upfront
05 Mar 2019 7:00 am
RNS
Karuna Appoints Chief Financial Officer
22 Feb 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
21 Feb 2019 7:00 am
RNS
PRTC to Present at Two US Investor Conferences
15 Feb 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
14 Feb 2019 7:00 am
RNS
Vor Raises $42M to Advance Leukaemia Treatment
28 Jan 2019 7:00 am
RNS
Alivio Partners to Advance Non-opioid Pain Therapy
23 Jan 2019 6:08 pm
RNS
Vedanta Immuno-oncology Candidate Published
02 Jan 2019 7:00 am
RNS
Total Voting Rights
28 Dec 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
24 Dec 2018 7:00 am
RNS
Vedanta Biosciences Raise $27M Series C Financing
17 Dec 2018 7:00 am
RNS
Vedanta Initiates Phase 2 Study for Lead Candidate
10 Dec 2018 7:00 am
RNS
Vedanta & BMS Immuno-Oncology Collaboration
28 Nov 2018 7:00 am
RNS
Vor Granted First-in-class Immuno-oncology Patent
27 Nov 2018 7:00 am
RNS
Janssen/Vedanta Phase 1 in IBD & $12M Milestone
26 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
22 Nov 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
16 Nov 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
14 Nov 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
13 Nov 2018 11:05 am
RNS
Full Gelesis Data Published in the Journal Obesity
07 Nov 2018 7:00 am
RNS
PRTC to Present at Jefferies 2018 in London
06 Nov 2018 1:00 pm
RNS
Vedanta Presents Data on Immuno-Oncology Candidate
05 Nov 2018 7:00 am
RNS
Gelesis to Present Full Data for Lead Candidate
31 Oct 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
26 Oct 2018 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
17 Oct 2018 7:00 am
RNS
Karuna Adds Sage Therapeutics CEO to Board
16 Oct 2018 12:20 pm
RNS
resTORbio Announces Additional Positive Ph 2b Data
15 Oct 2018 7:00 am
RNS
Karuna Initiates Phase 2 Study in Schizophrenia
04 Oct 2018 7:00 am
RNS
Vedanta Announces Successful Ph1 Clinical Results
17 Sep 2018 4:15 pm
RNS
Brain Lymphatics Published in Nature Neuroscience
12 Sep 2018 12:00 pm
RNS
Akili Exclusively Licenses New Digital Technology
  7:00 am
RNS
Alivio Awarded $3.3M Grant from US Dept of Defense
11 Sep 2018 7:00 am
RNS
PureTech Health plc - Half-Year Report
07 Sep 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
05 Sep 2018 7:00 am
RNS
Vedanta Adds Fmr Janssen Immunology Head to Board
29 Aug 2018 7:00 am
RNS
Notice of Results
15 Aug 2018 11:00 am
RNS
PureTech's Karuna Appoints Steven Paul, MD, as CEO
09 Aug 2018 7:01 am
RNS
PureTech's Akili Expands Series C Funding to $68M
02 Aug 2018 7:00 am
RNS
PureTech's Karuna Completes $42M Financing
01 Aug 2018 5:30 pm
RNS
Total Voting Rights
26 Jul 2018 7:00 am
RNS
Brain Lymphatics Programme Published in Nature
25 Jul 2018 12:02 pm
RNS
Price Monitoring Extension
  12:01 pm
RNS
PRTC: resTORbio Announces Positive Topline Results
20 Jul 2018 7:00 am
RNS
PRTC & Roche Announce Significant Collaboration
12 Jul 2018 7:00 am
RNS
PRTC: resTORbio Notes Publication of Phase 2a Data
10 Jul 2018 7:00 am
RNS
PRTC: Vedanta Awarded CCF Funding for IBD Program
27 Jun 2018 7:00 am
RNS
Additional Listing
20 Jun 2018 12:02 pm
RNS
Price Monitoring Extension
19 Jun 2018 7:05 am
RNS
PRTC: Karuna Receives $8M Wellcome Trust Award
  7:00 am
RNS
Director/PDMR Shareholding
13 Jun 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
05 Jun 2018 7:00 am
RNS
PRTC: Walgreens CMO joins Gelesis as CMO
30 May 2018 7:00 am
RNS
PRTC to Present at Jefferies US Conference
29 May 2018 12:02 pm
RNS
Price Monitoring Extension
25 May 2018 7:00 am
RNS
Director/PDMR Shareholding
22 May 2018 7:00 am
RNS
PRTC Alivio gets key patents for inflammation tech
18 May 2018 4:45 pm
RNS
Results of Annual General Meeting
09 May 2018 7:00 am
RNS
PRTC?s Akili Raises $55M from Leading Investors
02 May 2018 7:00 am
RNS
PureTech Affiliate Sonde Adds Thai Lee to Board
24 Apr 2018 7:00 am
RNS
PureTech Health Appoints Joep Muijrers as CFO
17 Apr 2018 4:35 pm
RNS
Price Monitoring Extension
16 Apr 2018 7:25 am
RNS
Final Results
10 Apr 2018 7:00 am
RNS
PRTC Affiliates Granted Key Digital Medicine IP
09 Apr 2018 8:25 am
RNS
PRTC's Commense Appoints President and CEO
04 Apr 2018 7:00 am
RNS
PRTC's Alivio Tech Published in Leading Journal
03 Apr 2018 4:17 pm
RNS
Result of Meeting
19 Mar 2018 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Mar 2018 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
15 Mar 2018 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
  7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
14 Mar 2018 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
  7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
13 Mar 2018 10:54 am
RNS
Circular Publication and Notice of General Meeting
  7:35 am
RNS
Results of Placing
12 Mar 2018 4:54 pm
RNS
Proposed Placing and Notice of General Meeting
01 Mar 2018 7:00 am
RNS
Gelesis Raises $30M; Prepares for Potential Launch
20 Feb 2018 7:00 am
RNS
Trading Statement
31 Jan 2018 7:00 am
RNS
PRTC resTORbio closes IPO, adds $13M to $85M raise
26 Jan 2018 7:00 am
RNS
PureTech's resTORbio successfully lists on NASDAQ
03 Jan 2018 7:00 am
RNS
PRTC's resTORbio Adds Senior Biogen Exec to Board
02 Jan 2018 7:00 am
RNS
PRTC's resTORbio Files Public S1 for NASDAQ IPO
19 Dec 2017 7:00 am
RNS
Lilly to invest $5M in PureTech's Entrega
13 Dec 2017 7:00 am
RNS
PureTech's Vedanta Granted Four New US Patents
11 Dec 2017 7:00 am
RNS
PureTech's resTORbio Adds Paul Fonteyne to Board
07 Dec 2017 7:00 am
RNS
PRTC: Vedanta Enters Clinic/FDA Orphan Designation
05 Dec 2017 3:14 pm
RNS
Increase of Holdings in Company
  7:00 am
RNS
PRTC's resTORbio Files IPO Registration Statement
04 Dec 2017 7:00 am
RNS
PureTech's Akili Pivotal ADHD Trial Successful
30 Nov 2017 7:00 am
RNS
PureTech's resTORbio Raises $40 Million
29 Nov 2017 7:00 am
RNS
PRTC's Vedanta Grows ImmunoOncology Collaborations
22 Nov 2017 7:00 am
RNS
PureTech to Present at Piper Jaffray Conference
20 Nov 2017 7:00 am
RNS
PRTC's Clinical-Stage Anti-Aging Compound Advances
09 Nov 2017 7:00 am
RNS
PRTC to Present at Jefferies 2017 in London
03 Nov 2017 7:00 am
RNS
PRTC: Vedanta Gets $5.4M for Antibiotic Resistance
01 Nov 2017 7:00 am
RNS
PRTC's Vedanta Licenses Microbiome IO Candidates
20 Oct 2017 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
27 Sep 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
26 Sep 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
25 Sep 2017 7:00 am
RNS
Research Update PRTC Gelesis Shows Efficacy/Safety
20 Sep 2017 7:00 am
RNS
PRTC Notes IP For Health Assessments from Speech
19 Sep 2017 7:00 am
RNS
PureTech Licenses Milk-Derived Exosome Technology
15 Sep 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
07 Sep 2017 5:00 pm
RNS
Director/PDMR Shareholding
04 Sep 2017 7:00 am
RNS
Director/PDMR Shareholding
31 Aug 2017 7:00 am
RNS
Total Voting Rights
30 Aug 2017 7:00 am
RNS
PureTech Health plc Half-year Report
29 Aug 2017 7:00 am
RNS
PureTech Licenses Glyph Lymphatic Technology
25 Aug 2017 5:11 pm
RNS
Additional Listing
02 Aug 2017 7:00 am
RNS
Notice of Results
31 Jul 2017 7:00 am
RNS
Director/PDMR Shareholding
13 Jul 2017 7:00 am
RNS
PureTech Presents Inflammation-Targeting Data
12 Jul 2017 7:00 am
RNS
PRTC's Gelesis Notes Last Patient in Pivotal Study
03 Jul 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
28 Jun 2017 2:08 pm
RNS
PRTC's Akili Names Former Cubist CEO Exec Chairman
26 Jun 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Jun 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
13 Jun 2017 6:05 pm
RNS
Holding(s) in Company
  6:01 pm
RNS
Holding(s) in Company
09 Jun 2017 5:40 pm
RNS
PDMR DEALING - PURCHASE OF SHARES
07 Jun 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
31 May 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
30 May 2017 7:00 am
RNS
PureTech's Vedanta Granted New US Patent
25 May 2017 7:00 am
RNS
PureTech Health to Present at Jefferies Conference
23 May 2017 7:01 am
RNS
PDMR DEALING - PURCHASE OF SHARES
  7:00 am
RNS
Director/PDMR Shareholding
19 May 2017 7:00 am
RNS
PureTech's Karuna to Present at 2 Medical Meetings
17 May 2017 7:00 am
RNS
PureTech's Sync Project Announces New Investors
16 May 2017 7:00 am
RNS
PureTech's Vedanta Granted Three New US Patents
09 May 2017 5:00 pm
RNS
Result of AGM
  7:00 am
RNS
PureTech Initiates Phase 2b mTORC1 Study in RTIs
  7:00 am
RNS
Annual Capital Markets Meeting
05 May 2017 7:00 am
RNS
PureTech Announces License for Microbiome Therapy
  7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
03 May 2017 2:00 pm
RNS
PureTech's Gelesis Receives Eur2.9 Million Award
02 May 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
24 Apr 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
13 Apr 2017 7:05 am
RNS
PDMR DEALING - PURCHASE OF SHARES
  7:00 am
RNS
Director/PDMR Shareholding
11 Apr 2017 7:00 am
RNS
PureTech Advances New Immuno-oncology Programme
10 Apr 2017 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
06 Apr 2017 7:00 am
RNS
PureTech's Akili Announces Pilot Study Results
  7:00 am
RNS
Final Results
24 Mar 2017 7:00 am
RNS
PureTech Announces Novartis Licensing Agreement
14 Mar 2017 7:00 am
RNS
Notice of Results
08 Mar 2017 7:00 am
RNS
PureTech Capital Markets Meeting in London 9 May
02 Mar 2017 7:00 am
RNS
PureTech Appoints Bharatt Chowrira as President
24 Feb 2017 7:00 am
RNS
PureTech to Present at Cowen & Co. Conference
23 Feb 2017 7:00 am
RNS
PureTech Health Appoints Atul Pande as CMO
16 Feb 2017 7:00 am
RNS
PureTech's Vedanta Announces 2 New Collaborations
07 Feb 2017 7:00 am
RNS
PureTech to Present at Leerink Conference
22 Dec 2016 7:00 am
RNS
Director/PDMR Shareholding
20 Dec 2016 4:53 pm
RNS
Research Update: Two Studies from Tal Medical
15 Dec 2016 7:00 am
RNS
Research Update: PureTech's Karuna data positive
09 Dec 2016 4:30 pm
RNS
PureTech's Akili and Pfizer Present Positive Data
04 Nov 2016 7:00 am
RNS
PureTech's Gelesis Presents Data at ObesityWeek
02 Nov 2016 7:00 am
RNS
PureTech to Present at Jefferies Conference
20 Oct 2016 7:00 am
RNS
PureTech Appoints Joseph Bolen as CSO
19 Oct 2016 7:00 am
RNS
PureTech's Vedanta Granted European Patent
03 Oct 2016 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
27 Sep 2016 7:00 am
RNS
Director/PDMR Shareholding
21 Sep 2016 7:00 am
RNS
Akili's Project:EVO Identifies Cognitive Deficits
12 Sep 2016 7:00 am
RNS
Karuna Doses First Subject in Tolerability POC
07 Sep 2016 7:00 am
RNS
Half-year Report
06 Sep 2016 7:00 am
RNS
Vedanta Biosciences Granted Third U.S. Patent
02 Sep 2016 7:00 am
RNS
Gelesis Appoints New Chief Operating Officer
23 Aug 2016 7:00 am
RNS
Notice of Results
  7:00 am
RNS
Vedanta Biosciences Granted Second U.S. Patent
16 Aug 2016 7:00 am
RNS
PureTech's Vedanta Biosciences Granted US Patent
11 Aug 2016 7:00 am
RNS
Vedanta and NYU Langone Medical Center Collaborate
27 Jul 2016 4:24 pm
RNS
Holding(s) in Company
22 Jul 2016 7:00 am
RNS
Holding(s) in Company
20 Jul 2016 7:00 am
RNS
Two Pharma Funds Invest in PureTech's Akili
12 Jul 2016 3:00 pm
RNS
Director/PDMR Shareholding
08 Jul 2016 7:00 am
RNS
PureTech Appoints Feng Zhang to SAB & Expands Team
28 Jun 2016 7:00 am
RNS
PureTech's Sonde Advances Vocal Biomarker Platform
24 Jun 2016 3:00 pm
RNS
Daphne Zohar 2016 EY Entrepreneur Of The Year
06 Jun 2016 7:00 am
RNS
Vedanta Biosciences Raises $50 Million
01 Jun 2016 4:30 pm
RNS
Topline Data from Tal Medical LFMS Study
31 May 2016 1:00 pm
RNS
PureTech to present at Jefferies Conference
20 May 2016 4:20 pm
RNS
Director/PDMR Shareholding
  4:20 pm
RNS
Holding(s) in Company
  4:12 pm
RNS
Director/PDMR Shareholding
10 May 2016 5:49 pm
RNS
Result of AGM
  7:00 am
RNS
First Capital Markets Meeting
  7:00 am
RNS
Launch of Alivio Therapeutics
09 May 2016 7:00 am
RNS
Launch of Vor BioPharma
06 May 2016 7:00 am
RNS
Akili Opens Enrolment for Pivotal Trial
05 May 2016 7:00 am
RNS
The Sync Project Teams with World-Renowned Artists
03 May 2016 7:00 am
RNS
Gelesis200 Positive Safety Results
  7:00 am
RNS
Director Dealing
26 Apr 2016 9:00 am
RNS
First US Patient Enrolled in Gelesis100 Study
07 Apr 2016 7:33 am
RNS
Final Results
31 Mar 2016 9:00 am
RNS
Expands Microbiome Focus with "Commense"
30 Mar 2016 9:00 am
RNS
Vedanta Biosciences Announces Licence with RIKEN
16 Mar 2016 9:00 am
RNS
Vedanta Appoints New Chief Scientific Officer
23 Feb 2016 9:00 am
RNS
Presenting at Cowen and Company Conference
16 Feb 2016 9:00 am
RNS
Notice of Results
27 Jan 2016 9:00 am
RNS
Expands SAB and appoints new Senior Advisors
22 Jan 2016 7:00 am
RNS
Operating Company Akili Raises $30.5 Million
19 Jan 2016 7:00 am
RNS
First Capital Markets Meeting
18 Dec 2015 7:00 am
RNS
Gelesis Closes $31.5m Growth Financing
30 Nov 2015 7:00 am
RNS
Names Scientific Advisory Board and Expands Team
05 Nov 2015 7:00 am
RNS
The Sync Project
02 Nov 2015 7:00 am
RNS
To Present at Jefferies 2015 Conference
28 Oct 2015 5:02 pm
RNS
Akili Study - Improved Attention & Memory in ADHD
26 Oct 2015 7:00 am
RNS
Director Dealing
09 Oct 2015 12:03 pm
RNS
Director Dealing
05 Oct 2015 7:00 am
RNS
Announcement Regarding Listing Rule 6.1.19R
01 Oct 2015 7:00 am
RNS
Director/PDMR Shareholding
28 Sep 2015 7:00 am
RNS
Director Dealing
24 Sep 2015 12:14 pm
RNS
Holding(s) in Company
16 Sep 2015 7:00 am
RNS
Director Dealing
14 Sep 2015 7:00 am
RNS
Appoints Michael MacLean as CFO
10 Sep 2015 9:30 am
RNS
Director Dealing
09 Sep 2015 9:17 am
RNS
Director Dealing
04 Sep 2015 4:00 pm
RNS
Follica Receives Notification of Patent Allowance
  8:15 am
RNS
Director Dealing
03 Sep 2015 7:00 am
RNS
Director Dealing
25 Aug 2015 7:00 am
RNS
Half Yearly Report
19 Aug 2015 12:00 pm
RNS
Notice of Half-Yearly Results
05 Aug 2015 7:00 am
RNS
Karuna Receives Wellcome Trust Award
27 Jul 2015 7:00 am
RNS
Gelesis Expands Ongoing Weight Loss Study
21 Jul 2015 3:40 pm
RNS
Holding(s) in Company
17 Jul 2015 12:26 pm
RNS
Director/PDMR Shareholding
07 Jul 2015 3:30 pm
RNS
Holding(s) in Company
03 Jul 2015 3:39 pm
RNS
Exercise of overallotment option - Admission
  7:01 am
RNS
Exercise of Over-allotment Option
  7:00 am
RNS
End of Stabilisation Notice
26 Jun 2015 3:18 pm
RNS
Holding(s) in Company
24 Jun 2015 4:25 pm
RNS
Holding(s) in Company
  8:00 am
RNS
Admission to Trading on the London Stock Exchange
19 Jun 2015 2:17 pm
RNS
Publication of Prospectus
  7:01 am
RNS
Stabilisation Notice
  7:00 am
RNS
Raises $171m in Premium List Main Market IPO
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t